![Mark Beveridge](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Beveridge
Director Financiero/CFO en
MOBERG PHARMA AB
.
Perfil
Mark Beveridge currently works at Biosergen AB, as Chief Financial Officer from 2025 and Moberg Pharma AB, as Vice President-Finance from 2015.
Mr. Beveridge also formerly worked at OncoZenge AB, as Chief Financial Officer.
Mr. Beveridge received his undergraduate degree from the University of Western Sydney.
Cargos activos de Mark Beveridge
| Empresas | Cargo | Inicio |
|---|---|---|
| MOBERG PHARMA AB | Director Financiero/CFO | 01/01/2015 |
| BIOSERGEN AB | Director Financiero/CFO | 24/07/2025 |
Antiguos cargos conocidos de Mark Beveridge.
| Empresas | Cargo | Fin |
|---|---|---|
| ONCOZENGE AB | Director Financiero/CFO | - |
Formación de Mark Beveridge.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
47
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
University of Western Sydney
 University of Western Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moberg Pharma AB
 Moberg Pharma AB Pharmaceuticals: MajorHealth Technology Develops and commercializes medical products | Health Technology |
OncoZenge AB
 OncoZenge AB Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that develops products for supportive care of cancer patients | Health Technology |
Biosergen AB
 Biosergen AB BiotechnologyHealth Technology Operates as a biotechnology company that develops antifungal drugs | Health Technology |
- Bolsa de valores
- Insiders
- Mark Beveridge
